Novo Nordisk (NVO) stock is trading at $49.69, recording a modest gain for the day. The price sits slightly below its key short-term moving average but remains above its medium- and long-term averages.
Highlights
- NVO/USD shows a mildly bullish short-term momentum with buyers dominating but some indicator divergence persists.
- The price currently trades at $49.69, up 0.87%, remaining above long-term support and mid-range for the day.
- Projected 2–3 day range is $48.64 to $50.74, with high probability of an upward move if resistance at $49.72 is breached.
Resistance at Kijun line as bullish signals diverge
On the hourly chart, NVO is positioned just below its 20-period moving average, but it remains above the 50-period moving average, while on the daily timeframe, the price stays above the 200-period moving average level. The Ichimoku Kijun line at $49.72 is acting as immediate resistance. Supporting indicators show a mixed but mildly bullish picture: the Moving Average Convergence Divergence (MACD), Average Directional Index (ADX), Relative Strength Index (RSI) at 54.96, Bull/Bear Power, and Stochastic RSI all indicate strong buy signals, while the Commodity Channel Index (CCI) and Awesome Oscillator provide a neutral outlook.
Range-bound action likely as resistance caps bullish risk
For the next two to three trading days, NVO is expected to hold within a volatility band of $48.64 to $50.74. The most probable scenario is continued range-bound movement, with a bullish breakout possible if the price closes above resistance near $49.72. A reversal to the downside would likely occur only if support at $48.64 is breached.
Earlier, analysts noted that Novo Nordisk shares were showing technical resilience and investor support despite mixed momentum signals. The current setup continues to favor a neutral-to-bullish bias, with particular attention warranted at the $49.72 resistance level for signs of an upside shift in trend.
Latest Novo Nordisk News
- Forex
- Crypto